Breaking News

SCHOTT, Hungarian Govt. Invest in Cutting-edge Syringe Production

€76 million investment at SCHOTT’s site in Lukácsháza designed to meet the growing global demand for prefillable syringes made of glass.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SCHOTT is further investing in its pharma business with plans to build new production for high-quality prefillable glass syringes (PFS) in Hungary. The €76 million investment is supported by the Hungarian government with about €9 million. The expansion is scheduled for completion in 2024 and is designed to create 120 new jobs.   “The added capacity will greatly benefit the global market and strengthen supply security for major pharmaceutical companies and contract manufacturing organizat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters